Analyst Consensus ?
ConsensusBuy33 ratings
Bullish2678.8%
Neutral721.2%
Bearish00.0%
FN2 Earnings Intelligence
MetLife, Inc. complete analyst coverage
MetLife, Inc. (MET) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$99.98Current
$68Low
$95.14Average
$145High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| UBS | Buy | Buy | Maintain | Oct 6, 2026 |
| Piper Sandler | Overweight | Neutral | Upgrade | Sep 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 24, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 11, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2024 |
| Argus Research | Buy | Buy | Maintain | May 22, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 9, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Raymond James | Perform | Market Perform | Maintain | Sep 22, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 22, 2022 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 19, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Mar 19, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jan 16, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Jul 16, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Jul 16, 2018 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Mar 26, 2018 |
| Argus | Buy | Buy | Maintain | Nov 6, 2017 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Feb 4, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 13, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jul 7, 2014 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 3, 2014 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $99.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Yaron Kinar | $109 | $97.16 | +9.0% | Oct 7, 2026 |
| Barclays | Analyst unavailable | $111 | $97.16 | +11.0% | Oct 7, 2026 |
| UBS | Michael Ward | $110 | $96.88 | +10.0% | Oct 6, 2026 |
| Piper Sandler | Paul Newsome | $110 | $96.64 | +10.0% | Sep 22, 2026 |
| Morgan Stanley | Bob Huang | $111 | $95.75 | +11.0% | Aug 24, 2026 |
| Wells Fargo | Analyst unavailable | $109 | $96.73 | +9.0% | Aug 19, 2026 |
| Barclays | Analyst unavailable | $97 | $96.26 | -3.0% | Aug 6, 2026 |
| Atlantic Equities | Analyst unavailable | $103 | $92.44 | +3.0% | Jul 15, 2026 |
| Jefferies | Suneet Kamath | $103 | $91.15 | +3.0% | Jul 10, 2026 |
| UBS | Michael Ward | $105 | $90.27 | +5.0% | Jul 8, 2026 |
| Barclays | Alex Scott | $94 | $90.46 | -6.0% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $90.93 | +3.0% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $90 | $88.03 | -10.0% | Jun 24, 2026 |
| Piper Sandler | Analyst unavailable | $86 | $84.06 | -14.0% | May 26, 2026 |
| Morgan Stanley | Bob Huang | $93 | $83.5 | -7.0% | May 21, 2026 |
| Wells Fargo | Analyst unavailable | $95 | $77.98 | -5.0% | May 12, 2026 |
| Mizuho Securities | Yaron Kinar | $95 | $78.82 | -5.0% | May 8, 2026 |
| Barclays | Alex Scott | $93 | $80.16 | -7.0% | May 7, 2026 |
| Mizuho Securities | Yaron Kinar | $93 | $74.63 | -7.0% | Apr 13, 2026 |
| Evercore ISI | Analyst unavailable | $96 | $74.65 | -4.0% | Apr 9, 2026 |
| UBS | Analyst unavailable | $102 | $74.65 | +2.0% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $100 | $78.89 | +0.0% | Feb 12, 2026 |
| Evercore ISI | Thomas Gallagher | $95 | $77.92 | -5.0% | Feb 10, 2026 |
| UBS | Analyst unavailable | $98 | $78.01 | -2.0% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $102 | $77.08 | +2.0% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $97 | $78.32 | -3.0% | Jan 13, 2026 |
| UBS | Analyst unavailable | $94 | $79.79 | -6.0% | Jan 8, 2026 |
| Barclays | Analyst unavailable | $90 | $79.47 | -10.0% | Jan 8, 2026 |
| Evercore ISI | Analyst unavailable | $97 | $81.77 | -3.0% | Jan 6, 2026 |
| Mizuho Securities | Analyst unavailable | $101 | $82.62 | +1.0% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $101 | $83.22 | +1.0% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $98 | $82.75 | -2.0% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $97 | $82.7 | -3.0% | Oct 7, 2025 |
| Piper Sandler | John Barnidge | $84 | $79.07 | -16.0% | Sep 19, 2025 |
| Wolfe Research | Tracy Benguigui | $95 | $80.46 | -5.0% | Sep 15, 2025 |
| Morgan Stanley | Bob Huang | $98 | $77.74 | -2.0% | Jul 14, 2025 |
| Piper Sandler | John Barnidge | $94 | $82.49 | -6.0% | Apr 2, 2025 |
| Morgan Stanley | Analyst unavailable | $109 | $86.18 | +9.0% | Feb 28, 2025 |
| Piper Sandler | John Barnidge | $92 | $81.78 | -8.0% | Oct 2, 2024 |
| Barclays | Alex Scott | $91 | $77.52 | -9.0% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $96 | $76.85 | -4.0% | Aug 1, 2024 |
| Morgan Stanley | Bob Huang | $83 | $69.92 | -17.0% | Jul 10, 2024 |
| Argus Research | Kevin Heal | $80 | $73.15 | -20.0% | May 22, 2024 |
| Piper Sandler | John Barnidge | $82 | $70.94 | -18.0% | May 6, 2024 |
| CFRA | Catherine Seifert | $77 | $72.67 | -23.0% | Mar 13, 2024 |
| Goldman Sachs | Alex Scott | $80 | $68.92 | -20.0% | Jan 8, 2024 |
| Mizuho Securities | Brett Linzey | $145 | $63.79 | +45.0% | Sep 14, 2023 |
| Morgan Stanley | Analyst unavailable | $90 | $72.68 | -10.0% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $88 | $71.35 | -12.0% | Jan 10, 2023 |
| Goldman Sachs | Analyst unavailable | $78 | $73.58 | -22.0% | Jan 9, 2023 |
| J.P. Morgan | Analyst unavailable | $80 | $73.58 | -20.0% | Jan 6, 2023 |
| Jefferies | Analyst unavailable | $82 | $73.61 | -18.0% | Dec 9, 2022 |
| Morgan Stanley | Analyst unavailable | $87 | $74.01 | -13.0% | Nov 17, 2022 |
| Credit Suisse | Analyst unavailable | $77 | $67.39 | -23.0% | Aug 22, 2022 |
| Morgan Stanley | Analyst unavailable | $83 | $67.25 | -17.0% | Aug 17, 2022 |
| Morgan Stanley | Analyst unavailable | $79 | $64.14 | -21.0% | Aug 4, 2022 |
| Barclays | Analyst unavailable | $75 | $57.79 | -25.0% | Jul 14, 2022 |
| Evercore ISI | Analyst unavailable | $80 | $61.4 | -20.0% | Jul 6, 2022 |
| Morgan Stanley | Analyst unavailable | $78 | $61.58 | -22.0% | Jul 6, 2022 |
| Wolfe Research | Charles Lederer | $74 | $61.75 | -26.0% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $80 | $67.23 | -20.0% | May 5, 2022 |
| Evercore ISI | Thomas Gallagher | $75 | $64.18 | -25.0% | Jan 5, 2022 |
| Goldman Sachs | Alex Scott | $77 | $58.92 | -23.0% | Dec 2, 2021 |
| Credit Suisse | Andrew Kligerman | $68 | $63.12 | -32.0% | May 13, 2021 |
| Argus Research | Kevin Heal | $72 | $65.2 | -28.0% | May 7, 2021 |
Track every rating change on MET the moment it posts. Free to start.
Start freeGet the MET recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.